COMMUNIQUÉS West-GlobeNewswire

Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
14/03/2024
SAN CARLOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, [...]
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
14/03/2024
Significant progress made in preparing for a Phase 2b study evaluating Vaxart’s oral pill XBB COVID-19 vaccine against an approved mRNA vaccine comparator Topline data from Phase 1 norovirus study in lactating mothers [...]
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
14/03/2024
Q4 2023 revenue of $7.3 million, representing a 109% increase from Q4 2022, marking the twelfth consecutive quarter of sequential product sales growth Full year 2023 revenues reached $31.6 million with product sales and [...]
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
14/03/2024
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis anticipated to complete enrollment in the second quarter of 2024. Company launches Individual Patient Expanded Access Program (EAP), allowing access to [...]
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
14/03/2024
Reported the First-Ever Durable Persistence of an Allogeneic Cellular Therapy from a Phase 1 Study of INB-100 in Leukemia where 100% of Evaluable Patients (n=10) Treated Remained in Remission, including six Patients [...]
Revolutionary Study at Ibogaine By David Dardashti Sheds Light on How Zodiac Signs Impact Treatment
14/03/2024
Quantum Physics and Astrology MIAMI, March 14, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to release the results of its lead researcher, Gavriel Dardashti's study analyzing the effects of astrological [...]
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
14/03/2024
Press Release Paris – March 14 th , 2024 – EUROAPI today announces that its Italian subsidiary, EUROAPI Italy S.R.L., is suspending the production of all APIs 1 in Brindisi. Following an internal audit, quality control [...]
Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie
14/03/2024
Communiqué de presse Paris – Le 14 mars 2024 – EUROAPI annonce aujourd’hui que sa filiale italienne EUROAPI Italy S.R.L. suspend la production de tous les APIs 1 sur son site de Brindisi. A la suite d’un audit interne, [...]
Fagron publishes annual report 2023
14/03/2024
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 14 March 2024 – 6:30 PM CET Fagron publishes annual report 2023 Fagron, the leading global player in pharmaceutical compounding, today publishes its [...]
Annual General Meeting in ALK-Abelló A/S held on 14 March 2024
14/03/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): ALK-Abelló A/S held its Annual General Meeting on 14 March 2024. The Annual General Meeting transacted the following business: Approval of the annual report 2023 and discharge of [...]
HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
14/03/2024
Clinical and pre-clinical data generated from collaborations between the Tuebingen University Hospital, researchers from the Mayo Clinic in Rochester (USA) and HepaRegeniX HRX-215 proved to be safe and well tolerated in [...]
IHA’s Symphony Chosen As Provider Directory Data Source for Covered California
14/03/2024
Symphony simplifies complex data exchange processes to ensure more accurate provider directory data for the state health insurance marketplace OAKLAND, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- The Integrated [...]
Sino Biological Announces Services Partnership with Rapid Novor
14/03/2024
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services BEIJING, China, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc. (“Sino Biological” or [...]
SafeGuard Surgical Receives FDA "Breakthrough" Designation, Secures Funding from Tom Pepin and NFL QB Jameis Winston
14/03/2024
Tampa, FL, March 14, 2024 (GLOBE NEWSWIRE) -- SafeGuard Surgical , a leading medical technology company focused on life-saving biodegradable solutions, announced today a major milestone in its mission to improve global [...]
Rick Simpson Oil California Introduces RSO Suppositories A New Path to Wellness Through Direct Absorption
14/03/2024
Rick Simpson Oil California Offers New RSO Suppositories for a Natural, Effective Alternative for Diverse Health Conditions LOS ANGELES, March 14, 2024 (GLOBE NEWSWIRE) -- In expanding its natural health remedies, Rick [...]
Revolutionizing Chronic Kidney Disease Management on World Kidney Day
14/03/2024
LifeLabs Klinrisk Score Included in KDIGO 2024 CKD Guideline Toronto, March 14, 2024 (GLOBE NEWSWIRE) -- Today, as the world marks World Kidney Day, LifeLabs, in exclusive partnership with Klinrisk, proudly announces a [...]
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
14/03/2024
FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a biotechnology company specializing in botanically based solutions that deliver high efficacy and low [...]
Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit
14/03/2024
Presentation Will Discuss Cellular Immunotherapy’s Potential Role in Treating Chronic Conditions and Extending People’s Lives FLORHAM PARK, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“ [...]
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
14/03/2024
NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]

Pages